Leading Tech Analyst Previews Earnings for Anadigics, Integrated Device
Technology, International Rectifier, Cavium, and Flextronics
PRINCETON, N.J., April 29, 2013
PRINCETON, N.J., April 29, 2013 /PRNewswire/ -- Next Inning Technology
Research (http://www.nextinning.com), an online investment newsletter focused
on technology stocks, has issued updated outlooks for Anadigics (Nasdaq:
ANAD), Integrated Device Technology (Nasdaq: IDTI), International Rectifier
(NYSE: IRF), Cavium (Nasdaq: CAVM), and Flextronics (Nasdaq: FLEX).
During 2012, Next Inning editor, Paul McWilliams predicted both the spring and
fall corrections as well as the rally that started in November and carried
through the first quarter of 2013. On the day the November rally started, he
advised readers it would lift the NASDAQ by as much at 18% by the end of March
2013. As we know now, that is exactly what happened.
To keep Next Inning readers ahead of the curve, Next Inning is now publishing
McWilliams' highly acclaimed earnings previews. These reports outline
McWilliams' outlook for the second quarter and provide readers with deep
insight into the world's leading tech companies. McWilliams also shares his
opinions as to which of these companies investors should buy and which should
Trial subscribers will also receive McWilliams' 167-page State of Tech report,
which includes 35 detailed tables and graphs, for free, no strings attached.
This report is a must read for investors and analysts focusing on technology
Already in 2013, McWilliams suggested buying several including Cree (up 62%
year to date), Micron (up 49% year to date), Marvell (up 45% year to date),
and SanDisk (up 24% year to date). Stocks he suggested avoiding/selling
include Netlist (down 28% year to date), Fairchild (down 13% year to date) and
Cypress (down 8% year to date). McWilliams' new earnings previews outline
which stocks investors will want to own and which they should avoid.
To get ahead of the Wall Street curve and receive McWilliams' Q1 2013 State or
Tech report, you are invited to take a free, 21-day, no obligation trial with
Next Inning. For full details on this offer, please visit the following link:
Topics discussed in the latest reports include:
-- Anadigics: What leads McWilliams to forecast Anadigics will imply, if not
guide for, a strong double digit revenue increase in calendar Q2 and that the
company will report revenue comfortably above $40M in Q4 2013? How does
McWilliams think Anadigics will use the funds it raised via a secondary
offering last quarter? What smartphone models are now using Anadigics'
technology? What three hurdles must Anadigics clear that will lead to a
notably higher price for the stock?
-- IDT: McWilliams suggested that Next Inning readers buy IDT in his Q3 2012
State of Tech report at the then current price of $5.87 and then, six months
later in his Q1 2013 State of Tech report, he wrote it was time to sell when
IDT was trading at $7.47. Since then, the price of IDT has dropped over 8%.
How is IDT positioned in the PCIe switch market, and why might this market see
stronger-than-expected growth? Do IDT shares have significant upside
potential if IDT executes in line with its strategy and Wall Street begins to
better recognize the new story at the company? Does McWilliams think it is
time to jump back in?
-- International Rectifier: Have the issues negatively impacting International
Rectifier during the past couple of years been company-specific,
market-specific or a combination of both? What event pushed the price of
International Rectifier up from its recent low in the $17s? At what price
should investors consider adding shares of the stock, and what is McWilliams'
-- Cavium: In his Q1 2013 State of Tech report, McWilliams strongly suggested
selling shares of Cavium. According to McWilliams, it's not Cavium's growth
prospects that should concern investors, it's the quality of Cavium's
earnings. Since that report was published, the price of Cavium has dropped
23%. What specific issues does McWilliams take with Cavium's non-GAAP
earnings presentation and what evidence does he point to on Cavium's balance
sheet and cash flow statement to support his opinions. Is Cavium likely to
face increased competitive threats going forward? With Cavium shares now
sharply lower, does McWilliams believe Cavium is due for a rebound or does he
think the price is destined to sink lower?
-- Flextronics: What caused McWilliams to adjust his rating on Flextronics
last year? Has McWilliams taken a more bullish or bearish view of Flextronics?
Does McWilliams expect that Flextronics will outperform expectations this
year? Why does McWilliams claim that investors should consider the potential
return on invested capital (ROIC) Flextronics will earn from its newly signed
deal to take over manufacturing for Motorola Mobility? What is his price
target for Flextonics? Trial subscribers will have full access to McWilliams'
highly acclaimed "Paradigm Paper" covering the EMS sector.
Founded in September 2002, Next Inning's model portfolio has returned 241%
since its inception versus 74% for the S&P 500.
About Next Inning:
Next Inning is a subscription-based investment newsletter that provides
regular coverage on more than 150 technology and semiconductor stocks.
Subscribers receive intra-day analysis, commentary and recommendations, as
well as access to monthly semiconductor sales analysis, regular Special
Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+
year semiconductor industry veteran.
NOTE: This release was published by Indie Research Advisors, LLC, a registered
investment advisor with CRD #131926. Interested parties may visit
adviserinfo.sec.gov for additional information. Past performance does not
guarantee future results. Investors should always research companies and
securities before making any investments. Nothing herein should be construed
as an offer or solicitation to buy or sell any security.
CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515
SOURCE Indie Research Advisors, LLC
Press spacebar to pause and continue. Press esc to stop.